Max Robotics — Global Service Robot Directory + US Certification

About

Hsiao‐Hsien Wang is a leading urological surgeon and researcher whose work centers on improving oncologic outcomes in prostate cancer surgery, particularly through robot-assisted radical prostatectomy (RARP). His major contributions lie in clarifying the delicate balance between nerve-sparing (NS) techniques and surgical margin status. In his highly cited 2021 study (36 citations), Wang conducted a comprehensive Asian-population, single-surgeon analysis to identify predictors of positive surgical margins (PSM) and biochemical recurrence (BCR), providing critical insights for risk stratification. He further advanced the field with his 2022 work (12 citations) that systematically examined how NS procedures impact PSM rates, addressing previously ambiguous findings. Wang’s research is notable for its rigorous methodology and direct clinical relevance, helping surgeons optimize functional preservation without compromising cancer control. His reply to commentary on this topic demonstrates his engagement with the scientific community and commitment to refining surgical practice. With a focused body of work that directly informs operative decision-making, Wang is a key voice in the ongoing effort to improve outcomes for prostate cancer patients undergoing robotic surgery.